scholarly article | Q13442814 |
P356 | DOI | 10.3899/JRHEUM.110170 |
P698 | PubMed publication ID | 21965707 |
P2093 | author name string | Daniel Wendling | |
Emmanuelle Dernis | |||
Clément Prati | |||
Bernard Delbosc | |||
Eric Frisch | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tocilizumab | Q425154 |
eye disease | Q3041498 | ||
P304 | page(s) | 2284 | |
P577 | publication date | 2011-10-01 | |
P1433 | published in | The Journal of Rheumatology | Q7743623 |
P1476 | title | Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect? | |
P478 | volume | 38 |
Q37632096 | A review and update on orphan drugs for the treatment of noninfectious uveitis |
Q38559007 | Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye. |
Q42147058 | Anti-interleukin-6 receptor antibody therapy-induced retinopathy in a patient with rheumatoid arthritis |
Q38169978 | Ocular inflammatory diseases associated with rheumatoid arthritis. |
Q34274075 | Pharmacotherapy for uveitis: current management and emerging therapy |
Q37600483 | Update on the use of systemic biologic agents in the treatment of noninfectious uveitis |
Q38021939 | Uveitis in seronegative arthritis |
Q52852545 | [Treatment of posterior noninfectious uveitis : Current situation and future developments]. |
Search more.